Cytosorbents Corp (DE:HQE1)
FRANKFURT:HQE1
Holding DE:HQE1?
Track your performance easily

Cytosorbents (HQE1) Financial Statements

0 Followers

Cytosorbents Financial Overview

Cytosorbents's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Cytosorbents is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is €-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 9.89M$ 9.79M$ 7.35M$ 8.81M$ 9.42M
Gross Profit$ 6.50M$ 6.57M$ 3.99M$ 5.61M$ 6.02M
EBIT$ -4.14M$ -6.36M$ -9.34M$ -9.19M$ -6.15M
EBITDA$ -3.70M$ -5.91M$ -8.55M$ -8.73M$ -5.70M
Net Income Common Stockholders$ -4.14M$ -6.36M$ -5.83M$ -9.19M$ -6.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.46M$ 8.61M$ 14.13M$ 8.36M$ 13.15M
Total Assets$ 53.43M$ 47.07M$ 53.26M$ 47.58M$ 52.44M
Total Debt$ 26.77M$ 17.61M$ 18.31M$ 18.04M$ 18.11M
Net Debt$ 18.31M$ 9.00M$ 4.18M$ 9.68M$ 4.96M
Total Liabilities$ 36.69M$ 28.14M$ 29.99M$ 29.06M$ 28.35M
Stockholders Equity$ 16.74M$ 18.93M$ 23.28M$ 18.51M$ 24.09M
Cash Flow-
Free Cash Flow$ -4.85M$ -4.96M$ -6.54M$ -5.46M$ -6.79M
Operating Cash Flow$ -4.79M$ -4.83M$ -6.41M$ -5.21M$ -6.93M
Investing Cash Flow$ -119.86K$ -127.02K$ -135.92K$ -257.71K$ 140.28K
Financing Cash Flow$ 9.83M$ -571.76K$ 12.21M$ 648.32K$ 931.12K
Currency in USD

Cytosorbents Earnings and Revenue History

Cytosorbents Debt to Assets

Cytosorbents Cash Flow

Cytosorbents Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis